Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization
- PMID: 38705159
- PMCID: PMC11140691
- DOI: 10.1016/S0140-6736(24)00850-X
Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization
Abstract
Background: WHO, as requested by its member states, launched the Expanded Programme on Immunization (EPI) in 1974 to make life-saving vaccines available to all globally. To mark the 50-year anniversary of EPI, we sought to quantify the public health impact of vaccination globally since the programme's inception.
Methods: In this modelling study, we used a suite of mathematical and statistical models to estimate the global and regional public health impact of 50 years of vaccination against 14 pathogens in EPI. For the modelled pathogens, we considered coverage of all routine and supplementary vaccines delivered since 1974 and estimated the mortality and morbidity averted for each age cohort relative to a hypothetical scenario of no historical vaccination. We then used these modelled outcomes to estimate the contribution of vaccination to globally declining infant and child mortality rates over this period.
Findings: Since 1974, vaccination has averted 154 million deaths, including 146 million among children younger than 5 years of whom 101 million were infants younger than 1 year. For every death averted, 66 years of full health were gained on average, translating to 10·2 billion years of full health gained. We estimate that vaccination has accounted for 40% of the observed decline in global infant mortality, 52% in the African region. In 2024, a child younger than 10 years is 40% more likely to survive to their next birthday relative to a hypothetical scenario of no historical vaccination. Increased survival probability is observed even well into late adulthood.
Interpretation: Since 1974 substantial gains in childhood survival have occurred in every global region. We estimate that EPI has provided the single greatest contribution to improved infant survival over the past 50 years. In the context of strengthening primary health care, our results show that equitable universal access to immunisation remains crucial to sustain health gains and continue to save future lives from preventable infectious mortality.
Funding: WHO.
Copyright © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of interests CLT and KAMG assert that their employer, Imperial College, receives funding for the Vaccine Impact Modelling Consortium from the Bill & Melinda Gates Foundation; Gavi, the Vaccine Alliance; and the Wellcome Trust. CLT has received consulting fees from GSK for attending an advisory board meeting on CMV vaccines in May, 2022 and is pro bono Chair of the Scientific Advisory Panel of the Meningitis Research Foundation. HF asserts that her employer, London School of Hygiene & Tropical Medicine, receives funding for the Vaccine Impact Modelling Consortium from the Gates Foundation. JFM asserts that his employer, University of Washington, receives grant funding from Gavi and from the Gates Foundation. KB and KMT assert that their organisation Kid Risk holds a cooperative agreement with the US Centers for Disease Control and Prevention and holds grants from the Gates Foundation. MJF asserts that his employer, Penn State University, is a subrecipient of funds from Imperial College London for a grant from Gavi and that he holds grants from the Gates Foundation and the US National Science Foundation. MJ asserts that his employer, London School of Hygiene & Tropical Medicine, receives funding from the UK National Institute of Health Research, RCUK; the Gates Foundation; Gavi; the Wellcome Trust; WHO; the European Commission; the US Centers for Disease Control and Prevention; the Hong Kong Special Administrative Region Government; and the Task Force for Global Health. RAH and SPS assert that their employer, University of Cape Town, receives grant funding from the African Field Epidemiology Network and the US Centers for Disease Control and Prevention. RGW asserts that he receives funding from the Wellcome Trust (grant numbers 218261/Z/19/Z), National Institutes of Health (1R01AI147321-01, G-202303-69963, and R-202309-71190), European and Developing Countries Clinical Trials Partnership (RIA208D-2505B), UK Medical Research Council (CCF17-7779 via SET Bloomsbury), UK Economic and Social Research Council (ES/P008011/1), Bill & Melinda Gates Foundation (INV-004737 and INV-035506), and WHO (2020/985800-0). AL, KLO-B, NB-Z, PL, RCWH, and SYS work for WHO. All other authors declare no competing interests.
Figures



Comment in
-
Expanded Programme on Immunization at 50 years: its legacy and future.Lancet. 2024 May 25;403(10441):2265-2267. doi: 10.1016/S0140-6736(24)00982-6. Lancet. 2024. PMID: 38796196 No abstract available.
Similar articles
-
Modeling the impact of vaccination for the immunization Agenda 2030: Deaths averted due to vaccination against 14 pathogens in 194 countries from 2021 to 2030.Vaccine. 2024 Apr 8;42 Suppl 1:S28-S37. doi: 10.1016/j.vaccine.2023.07.033. Epub 2023 Aug 1. Vaccine. 2024. PMID: 37537094
-
Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050.Lancet. 2024 Sep 28;404(10459):1199-1226. doi: 10.1016/S0140-6736(24)01867-1. Epub 2024 Sep 16. Lancet. 2024. PMID: 39299261 Free PMC article.
-
Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010.Lancet. 2012 Dec 15;380(9859):2071-94. doi: 10.1016/S0140-6736(12)61719-X. Lancet. 2012. PMID: 23245603
-
Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021.Lancet Infect Dis. 2024 Sep;24(9):974-1002. doi: 10.1016/S1473-3099(24)00176-2. Epub 2024 Apr 15. Lancet Infect Dis. 2024. PMID: 38636536 Free PMC article.
-
BCG vaccination in India and tuberculosis in children: newer facets.Indian J Pediatr. 1994 Sep-Oct;61(5):451-62. doi: 10.1007/BF02751703. Indian J Pediatr. 1994. PMID: 7744445 Review.
Cited by
-
Vaccines for neglected tropical diseases: Learnings from COVID-19.Indian J Med Res. 2024 Sep&Oct;160(3&4):319-322. doi: 10.25259/IJMR_1548_2024. Indian J Med Res. 2024. PMID: 39632633 Free PMC article. No abstract available.
-
Boosting effect of high-dose influenza vaccination on innate immunity among elderly.JCI Insight. 2025 Mar 4;10(8):e184128. doi: 10.1172/jci.insight.184128. eCollection 2025 Apr 22. JCI Insight. 2025. PMID: 40036077 Free PMC article. Clinical Trial.
-
Designing a National Rapid Vaccine Coverage Survey in low-resource settings: Experiences from the Democratic Republic of the Congo 2018-2023.Vaccine. 2025 Apr 19;53:126956. doi: 10.1016/j.vaccine.2025.126956. Epub 2025 Mar 2. Vaccine. 2025. PMID: 40031089 Free PMC article.
-
Comparison of life expectancy determinants among gulf cooperation council members.BMC Public Health. 2025 Jan 15;25(1):161. doi: 10.1186/s12889-025-21296-4. BMC Public Health. 2025. PMID: 39815262 Free PMC article.
-
Expanded Programme on Immunization (EPI): A Legacy of 50 Years and the Road Ahead.Vaccines (Basel). 2025 Jun 17;13(6):649. doi: 10.3390/vaccines13060649. Vaccines (Basel). 2025. PMID: 40573980 Free PMC article.
References
-
- World Health Assembly WHO expanded programme on immunization. 1974. https://iris.who.int/handle/10665/92778
-
- Cornejo S, Chevez A, Ozturk M, et al. [The Pan American Health Organization's Revolving Fund for access to vaccines: 43 years responding to the regional immunization programO Fundo Rotativo para Acesso a Vacinas da Organização Pan-Americana da Saúde: 43 anos respondendo ao Programa Regional de Imunizações] Rev Panam Salud Publica. 2023;47:e50. - PMC - PubMed
-
- UNICEF Moving with the times: 1980–1988—discover the importance of data and research in UNICEF's efforts for child survival and development. 2018. https://www.unicef.org/stories/learning-experience-19801988
-
- O'Brien K. World Health Organization; Geneva: 2024. From the expanded to the essential programme on immunization: achievements of the last 50 years and inspirations for the next 50. IVB Director's Report to SAGE.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous